JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8717 THZ2
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥28.3 mg/mL
A4112 Barasertib (AZD1152-HQPA)
3 Citation

Target: Aurora Kinases

Summary: Aurora Kinase B inhibitor, Potent and selective

≥25.4 mg/mL
A4118 Hesperadin
1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor

≥25.85 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A4393 Paclitaxel (Taxol)
4 Citation

Target: Microtubules/Tubulins

Summary: Antineoplastic agent

≥85.6 mg/mL
A3214 AZD1152
1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor,highly potent and selective

insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
A3742 Pyridostatin
2 Citation

Target: G-quadruplexes

Summary: Drug used for promoting growth arrest

≥20.85 mg/mL
A5343 Ispinesib (SB-715992)

Target: Ksp

Summary: Kinesin spindle protein (KSP)inhibitor

≥25.85 mg/mL
A5919 AZD7762

Target: Chk

Summary: Checkpoint kinase inhibitor,ATP competitive

insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
A1986 Nu 6027

Target: Cyclin-Dependent Kinases|ATM/ATR

Summary: ATR/CDK inhibitor, potent and selective

insoluble in H2O; ≥12.55 mg/mL